Equities

HeiLongJiang ZBD Pharmaceutical Co Ltd

603567:SHH

HeiLongJiang ZBD Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)10.05
  • Today's Change-0.12 / -1.18%
  • Shares traded1.68m
  • 1 Year change-18.43%
  • Beta0.8427
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,4611,0421,458
Total Receivables, Net4,6323,9764,300
Total Inventory7211,006733
Prepaid expenses34533978
Other current assets, total7.9219107
Total current assets7,1686,3816,676
Property, plant & equipment, net1,6091,6571,556
Goodwill, net151719
Intangibles, net994963349
Long term investments2,0542,0872,130
Note receivable - long term------
Other long term assets------
Total assets12,46611,67511,506
LIABILITIES
Accounts payable319793654
Accrued expenses484236
Notes payable/short-term debt9611,428802
Current portion long-term debt/capital leases9761,1551,050
Other current liabilities, total450450270
Total current liabilities2,7553,8672,812
Total long term debt1,2984701,294
Total debt3,2363,0523,146
Deferred income tax263.671.37
Minority interest4927.948.27
Other liabilities, total346228348
Total liabilities4,9174,5774,463
SHAREHOLDERS EQUITY
Common stock942942942
Additional paid-in capital2,3442,3502,350
Retained earnings (accumulated deficit)4,2853,8373,751
Treasury stock - common(22)(30)--
Unrealized gain (loss)------
Other equity, total0.05(0.14)--
Total equity7,5487,0997,043
Total liabilities & shareholders' equity12,46611,67511,506
Total common shares outstanding939939942
Treasury shares - common primary issue2.702.560
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.